A conserved arginine in the distal third intracellular loop of the μ- opioid receptor is required for G protein activation

Journal of Neurochemistry

Volumn 72, Issue 3, 1999, Pages 1307-1314

  Wang, Hung Li ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Opioid receptor; D Ala2,N Me Phe4,Gly ol5 enkephalin; Adenylate cyclase; G(i) proteins; HEK 293 cells

Indexed keywords

ADENYLATE CYCLASE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENYLATE CYCLASE; ANIMALS; ARGININE; CELL LINE; CLONING, MOLECULAR; CYCLIC AMP; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; FORSKOLIN; GTP-BINDING PROTEINS; HUMANS; KIDNEY; LIGANDS; MUTATION; RADIOLIGAND ASSAY; RATS; RECEPTORS, OPIOID, MU;

EID: 0033048623     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0721307.x     Document Type: Article

References (42)

1. Benya R. V., Akeson M., Mrozinski J., Jensen R., and Battey J. F. (1994) Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. Mol. Pharmacol. 46, 495-501.
2. Brodbeck R. M., Sachais B. S., and Krause J. E. (1995) Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses. Mol. Pharmacol. 47, 1065-1071.
3. Burstein E. S., Spalding T. A., Hill-Eubanks D., and Brann M. R. (1995) Structure-function of muscarinic receptor coupling to G proteins: random saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins. J. Biol. Chem. 270, 3141-3146.
4. Chen Y., Mestek A., Liu J., Hurley J. A., and Yu L. (1993) Molecular cloning and functional expression of a μ opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
5. Childers S. R. (1993) Opioid receptor-coupled second messenger system, in Handbook of Experimental Pharmacology, Vol. 104, Pt. 1: Opioids I (Hertz A., ed), pp. 189-216. Springer-Verlag, New York.
6. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological functions. Proc. Natl. Acad. Sci. USA 87, 2896-2900.
7. 2A-adrenergic receptor. J. Biol. Chem. 271, 12826-12832.
8. Gudermann T., Schoneberg T., and Schultz G. (1997) Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu. Rev. Neurosci. 20, 399-427.
9. Hirst R. A., Smart D., Devi L. A., and Lambert D. G. (1998) Effects of C-terminal truncation of the recombinant δ-opioid receptor on phospholipase C and adenylyl cyclase coupling. J. Neurochem. 70, 2273-2278.
10. Ito W., Ishiguro H., and Kurosawa Y. (1991) A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction. Gene 102, 67-70.
11. q subunits. Biochemistry 36, 1487-1495.
12. Kovoor A., Nappey V., Kieffer B. L., and Chavkin C. (1997) μ and δ receptors are differentially desensitized by the coexpression of β-adrenergic receptor kinase 2 and β-arrestin 2 in Xenopus oocytes. J. Biol. Chem. 272, 27605-27611.
13. Kunkel M. T. and Peralta E. G. (1993) Charged amino acids required for signal transduction by the m3 muscarinic acetylcholine receptor. EMBO J. 12, 3809-3815.
14. Lechleiter J., Hellmiss R., Duerson K., Ennulat D., David N., Clapham D., and Peralta E. (1990) Distinct sequence elements control the specificity of G protein by muscarinic acetylcholine receptor subtypes. EMBO J. 9, 4381-4390.
15. Lee N. H., Geoghagen N. S. M., Cheng E., Cline R. T., and Fraser C. M. (1996) Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on ml muscarinic acetylcholine receptors. Mol. Pharmacol. 50, 140-148.
16. 1A receptor by protein kinase C. Mol. Pharmacol. 48, 1027-1029.
17. 1A receptor directs signaling specificity. Mol. Pharmacol. 52, 164-171.
18. Liu J. and Wess J. (1996) Different single receptor domains determine the distinct protein coupling profiles of members of vasopressin receptor family. J. Biol. Chem. 271, 8772-8778.
19. Liu J., Conklin B. R., Blin N., Yun J., and Wess J. (1995) Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. Proc. Natl. Acacl. Sci. USA 92, 11642-11646.
20. Loh H. H. and Smith A. P. (1990) Molecular characterizations of opioid receptors. Annu. Rev. Pharmacol. Toxicol. 30, 123-147.
21. Maeda S., Lameh J., Mallet W. G., Philip M., Ramachandran J., and Sadee W. (1990) Internalization of the Hm1 muscarinic cholinergic receptor involves the third cytoplasmic loop. FEBS Lett. 269, 386-388.
22. Mansour A., Fox A. C., Akil H., and Waston S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29.
23. i protein by peptide structures of the muscarinic M2 receptor second intracellular loop. Eur. J. Pharmacol. 267, 185-193.
24. Merkouris M., Dragatsis I., Meraritis G., Konidakis G., Zioudrou C., Milligan G., and Georgoussi Z. (1996) Identification of the critical domains of the δ-opioid receptor involved in G protein coupling using site-specific synthetic peptides. Mol. Pharmacol. 50, 985-993.
25. Namba E., Sugimoto Y., Negishi M., Irie A., Ushikubi F., Kakizuka A., Ito S., Ichikawa A., and Narumiya S. (1993) Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365, 166-170.
26. North R. A. (1993) Opioid actions on membrane ion channels, in Handbook of Experimental Pharmacology, Vol. 104, Pt. 1: Opioids I (Hertz A., ed), pp. 773-797. Springer-Verlag, New York.
27. 2-adrenergic receptors based upon characteristics in primary structure. J. Biol. Chem. 267, 8342-8346.
28. oα by peptides representing sequence permutations of mastoparan. Proc. Natl. Acad. Sci. USA 89, 8268-8272.
29. Pak J. S., O'Dowd B. F., and George S. (1997) Agonist-induced desensitization of the μ opioid receptor is determined by threonine 394 preceded by acidic amino acids of the COOH-terminal tail. J. Biol. Chem. 272, 24961-24965.
30. Reisine T. and Bell G. I. (1993) Molecular biology of the opiate receptors. Trends Neurosci. 16, 384-389.
31. 2-adrenergic receptor. J. Biol. Chem. 268, 16483-16487.
32. Savarese T. M. and Fraser C. M. (1992) In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J. 283, 1-19.
33. Strader C. D., Fong T. M., Michael R. T., Underwood D., and Dixon R. A. F. (1994) Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63, 101-132.
34. Sukumar M. and Higashijima T. (1992) G protein-bound conformation of mastoparan-X, a receptor-mimetic peptide. J. Biol. Chem. 267, 21421-21424.
35. Thompson R. C., Mansour A., Akil H., and Watson S. J. (1993) Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 11, 903-913.
36. Trapaidze N., Keith D. E., Cvejic S., Evans C. J., and Devi L. A. (1996) Sequestration of the δ opioid receptor: role of the C-terminus in agonist-mediated internalization. J. Biol. Chem. 271, 29279-29285.
37. 2-adrenergic receptor i3c region. Mol. Pharmacol. 50, 351-358.
38. q coupling by the use of receptor chimeras. J. Biol. Chem. 270, 16677-16682.
39. Wang H.-L. (1997) Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors. J. Neurochem. 68, 1728-1735.
40. Wang J. B., Johnson P. S., Persico A. M., Hawkins A. L., Griffin C. A., and Uhl G. R. (1994) Human μ opiate receptor: cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 338, 217-222.
41. s in response to muscarinic agonists. J. Biol. Chem. 265, 6219-6224.
42. Zaki P. A., Bilsky E. J., Vanerah T. W., Lai J., Evans C. J., and Porreca F. (1996) Opioid receptor types and subtypes: the δ receptor as a model. Annu. Rev. Pharmacol. Toxicol. 36, 379-401.